Shenzhen Bioeasy Biotechnology Co. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenzhen Bioeasy Biotechnology Co. Ltd.

Why is Shenzhen Bioeasy Biotechnology Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -2.07% and Operating profit at -22.69% over the last 5 years

With a growth in Net Profit of 175.85%, the company declared Very Positive results in Sep 25

ROCE(HY) Highest at 3.55%
RAW MATERIAL COST(Y) Fallen by -13.39% (YoY)
NET SALES(Q) Highest at CNY 76.17 MM

With ROE of 2.03%, it has a expensive valuation with a 4.84 Price to Book Value

Over the past year, while the stock has generated a return of -6.24%, its profits have risen by 115% ; the PEG ratio of the company is 2.1

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -6.24% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shenzhen Bioeasy Biotechnology Co. Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shenzhen Bioeasy Biotechnology Co. Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shenzhen Bioeasy Biotechnology Co. Ltd.

-6.24%

0.70

49.65%

China Shanghai Composite

16.01%

1.07

14.97%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.07%

EBIT Growth (5y)

-22.69%

EBIT to Interest (avg)

42.88

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.20

Tax Ratio

7.11%

Dividend Payout Ratio

40.94%

Pledged Shares

Institutional Holding

ROCE (avg)

27.09%

ROE (avg)

8.10%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

238

Industry P/E

Price to Book Value

4.84

EV to EBIT

296.21

EV to EBITDA

117.23

EV to Capital Employed

5.28

EV to Sales

17.91

PEG Ratio

2.07

Dividend Yield

ROCE (Latest)

1.78%

ROE (Latest)

2.03%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company

ROCE(HY)

Highest at 3.55%

RAW MATERIAL COST(Y)

Fallen by -13.39% (YoY

NET SALES(Q)

Highest at CNY 76.17 MM

PRE-TAX PROFIT(Q)

Highest at CNY 17.66 MM

NET PROFIT(Q)

Highest at CNY 15.71 MM

EPS(Q)

Highest at CNY 0.04

-14What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 34.5 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.54 times

INTEREST(Q)

Highest at CNY 6.91 MM

Here's what is working for Shenzhen Bioeasy Biotechnology Co. Ltd.

Net Profit

At CNY 15.71 MM has Grown at 246.86%

over average net sales of the previous four periods of CNY 4.53 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 76.17 MM has Grown at 32.58%

over average net sales of the previous four periods of CNY 57.45 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 17.66 MM has Grown at 146.49%

over average net sales of the previous four periods of CNY 7.16 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Sales

Highest at CNY 76.17 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 17.66 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 15.71 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.04

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -13.39% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenzhen Bioeasy Biotechnology Co. Ltd.

Operating Cash Flow

Lowest at CNY 34.5 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

Highest at CNY 6.91 MM

in the last five periods and Increased by 8.82% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 2.54 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio